ONK Therapeutics and NAYA Biosciences Announce Research Partnership
06 Dec 2023 //
GLOBENEWSWIRE
European Patent Office Grants ONK Therapeutics Patent for CISH Knockou
27 Jun 2023 //
GLOBENEWSWIRE
ONK Therapeutics Boosts Drug Development Experience and Expands US Presence
06 Dec 2022 //
GLOBENEWSWIRE
ONK Presents In-Vivo Data of its Optimized Affinity CD38 CAR-NK Candidate
29 Aug 2022 //
BUSINESSWIRE
ONK Therapeutics Brings in US Financial Experience; Appoints Dr. Allan Reine
23 Mar 2022 //
PRNEWSWIRE
Intellia-ONK sign $920M pact on CRISPR-edited cell therapies
16 Feb 2022 //
THEPHARMALETTER
ONK Therapeutics Announces $21.5M Series A Financing to Advance Pipeline
05 Jan 2022 //
BUSINESSWIRE